Brodimoprim
![]() | |
Clinical data | |
---|---|
ATC code | J01EA02 (WHO) |
Identifiers | |
| |
CAS Number |
56518-41-3 ![]() |
PubChem (CID) | 68760 |
ChemSpider |
62004 ![]() |
UNII |
V1YC7T6LLI ![]() |
KEGG |
D07238 ![]() |
ChEBI | CHEBI:131726 |
ChEMBL |
CHEMBL31891 ![]() |
ECHA InfoCard | 100.054.745 |
Chemical and physical data | |
Formula | C13H15BrN4O2 |
Molar mass | 339.188 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(verify) |
Brodimoprim is a structural derivative of trimethoprim. In brodimoprim, the 4-methoxy group of trimethoprim is replaced with a bromine atom.
As trimethoprim, brodimoprim is a selective inhibitor of bacterial dihydrofolate reductase.[1]
References
This article is issued from Wikipedia - version of the 4/15/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.